Never too old to benefit from lipid-lowering treatment

Affiliations

¹ Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa. Electronic address: frederick.raal@wits.ac.za.
² Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.

Comment

Frederick J Raal et al. Lancet. 2020.

. 2020 Nov 21;396(10263):1608-1609.

doi: 10.1016/S0140-6736(20)32333-3. Epub 2020 Nov 10.

¹ Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa. Electronic address: frederick.raal@wits.ac.za.
² Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.

No abstract available

Comment on

Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort.
Mortensen MB, Nordestgaard BG. Mortensen MB, et al. Lancet. 2020 Nov 21;396(10263):1644-1652. doi: 10.1016/S0140-6736(20)32233-9. Epub 2020 Nov 10. Lancet. 2020. PMID: 33186534
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials.
Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, Braunwald E, Giugliano RP, Sabatine MS. Gencer B, et al. Lancet. 2020 Nov 21;396(10263):1637-1643. doi: 10.1016/S0140-6736(20)32332-1. Epub 2020 Nov 10. Lancet. 2020. PMID: 33186535 Free PMC article.